Teruhisa Kato

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Respiratory Syndrome Coronavirus

Top Venues

The Journal of antimicrobial chemotherapy

Science translational medicine

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Keita Fukao, Haruaki Nobori, Takayuki Kuroda, Kaoru Baba, Kazumi Matsumoto, Yukari Tanaka, Yuki Tachibana, Teruhisa Kato, Takao Shishido
Pharmacokinetic and Pharmacodynamic Analysis of the 3CL Protease Inhibitor Ensitrelvir in a SARS-CoV-2 Infection Mouse Model. Viruses 15 (10) (2023)
Shuhei Yoshida, Yusuke Sako, Eiji Nikaido, Taichi Ueda, Iori Kozono, Yusuke Ichihashi, Atsufumi Nakahashi, Motoyasu Onishi, Yukiko Yamatsu, Teruhisa Kato, Junichi Nishikawa, Yuki Tachibana
Peptide-to-Small Molecule: Discovery of Non-Covalent, Active-Site Inhibitors of β-Herpesvirus Proteases. ACS medicinal chemistry letters 14 (11) (2023)
Takayuki Kuroda, Haruaki Nobori, Keita Fukao, Kaoru Baba, Kazumi Matsumoto, Shinpei Yoshida, Yukari Tanaka, Ryosuke Watari, Ryoko Oka, Yasuyuki Kasai, Kae Inoue, Sho Kawashima, Alice Shimba, Yoko Hayasaki-Kajiwara, Miki Tanimura, Qianhui Zhang, Yuki Tachibana, Teruhisa Kato, Takao Shishido
Efficacy comparison of 3CL protease inhibitors ensitrelvir and nirmatrelvir against SARS-CoV-2 in vitro and in vivo. The Journal of antimicrobial chemotherapy (2023)
Haruaki Nobori, Keita Fukao, Takayuki Kuroda, Naomi Anan, Ryoichi Tashima, Masaaki Nakashima, Sayuri Noda, Minako Tajiri, Mikinori Torii, Shinsuke Toba, Kentaro Uemura, Takao Sanaki, Takao Shishido, Yuki Tachibana, Teruhisa Kato
Efficacy of ensitrelvir against SARS-CoV-2 in a delayed-treatment mouse model. The Journal of antimicrobial chemotherapy 77 (11) (2022)
Michihito Sasaki, Koshiro Tabata, Mai Kishimoto, Yukari Itakura, Hiroko Kobayashi, Takuma Ariizumi, Kentaro Uemura, Shinsuke Toba, Shinji Kusakabe, Yuki Maruyama, Shun Iida, Noriko Nakajima, Tadaki Suzuki, Shinpei Yoshida, Haruaki Nobori, Takao Sanaki, Teruhisa Kato, Takao Shishido, William W Hall, Hirofumi Sawa, Akihiko Sato, Hirofumi Sawa
S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral load and ameliorates COVID-19 severity in hamsters. Science translational medicine (2022)